戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 In addition, tsetse PGRP-LB may have an anti-protozoal activity that confers parasite resistance.
2               The phylogeny of the commonest protozoal agent of intestinal disease, Giardia, is uncle
3 by higher detection of metabolites from both protozoal and bacterial activity.
4 ndicate that microbiome variation across key protozoal and bacterial populations is interlinked, whic
5 s recently shown promise in the treatment of protozoal and fungal diseases, most notably, leishmanias
6  extensively as a drug target for bacterial, protozoal and fungal infections, and also for neoplastic
7             Using the structures of both the protozoal and human enzymes, we have developed inhibitor
8  biological activities (anti-microbial, anti-protozoal, and cytotoxic) of its methanolic and hexane e
9                       Analysis of bacterial, protozoal, and fungal dsRNA viruses has improved our und
10 tory monocytes in defense against bacterial, protozoal, and fungal pathogens.
11 to opportunistic organisms-bacterial, viral, protozoal, and others-and such infections may be more se
12 n of the most important foodborne bacterial, protozoal, and viral diseases.
13 , we now show that the mitogenic property of protozoal antigen preparations is in part attributable t
14 ered mammalian, plant, yeast, bacterial, and protozoal cells in seconds to minutes via a nonendocytic
15 iated with a longer duration of diarrhea and protozoal coinfections with increased odds of hospitaliz
16 phenotype nor genotype but instead linked to protozoal community patterns.
17 ion (16%) while increasing local groundwater protozoal contamination (87-306%), with the largest incr
18 ausing IFD and additionally provided partial-protozoal coverage.
19 ecessary to improve the staining quality for protozoal cysts fixed in STF to a level comparable to th
20 ia risk: agents against amoebiasis and other protozoal diseases (106 genes, p=0.00046, pcorrected =0.
21 r the treatment of leishmaniasis, a group of protozoal diseases that includes visceral leishmaniasis,
22                           The recognition of protozoal DNA by B lymphocytes and macrophages may provi
23 tudies have reported mitogenic properties of protozoal DNA for any species.
24 12, TNF-alpha, and NO induced by E. coli and protozoal DNA were strongly correlated (r2 > 0.9) with t
25 ill raise the possibility of developing anti-protozoal drugs with minimal toxic side affects.
26              Moreover, GLV is the only known protozoal dsRNA virus that can transmit efficiently by e
27   In agreement with its unique capacity as a protozoal dsRNA virus to survive and transmit through ex
28 through gravimetric separation to create the protozoal-enriched inoculum (PE).
29  bacterial, five viral, four fungal, and one protozoal enzyme.
30  to identify the likely bacterial, viral and protozoal etiologies.
31 0)LEYEF(184)), which define the fungal/viral/protozoal family of metal-dependent RNA triphosphatases.
32 gic (bacterial, fungal, archaeal, viral, and protozoal) features of the intestine separate its nearly
33                                          The protozoal/fungal enzymes are structurally and mechanisti
34  activity, was caused by the decrease in the protozoal grazing due to the higher inhibition of ciliat
35  ecology of bioengineered systems to include protozoal grazing, especially under perturbation scenari
36 be involved in host immune modulation during protozoal infection and may be useful as vaccine adjuvan
37 antibiotic for the control of coccidiosis, a protozoal infection in poultry and rabbits.
38 for visceral leishmaniasis, an intracellular protozoal infection of tissue macrophages.
39 l-mediated immunity to viral, bacterial, and protozoal infection.
40 % with TGF-beta1, even in the face of active protozoal infection; and epithelial cell necrosis monito
41 ndependent methods for bacterial, viral, and protozoal infections (eg, polymerase chain reaction [PCR
42 eutics against HIV/AIDS-associated bacterial/protozoal infections and neoplasms, we investigated whet
43                                     Tropical protozoal infections are a significant cause of morbidit
44 hology is emerging in bacterial, fungal, and protozoal infections at mucocutaneous tissues.
45  D2 sequencing diagnosed 5 cases of invasive protozoal infections due to Toxoplasma gondii (n = 3), T
46                            Non-STH parasitic/protozoal infections in the non-STH-endemic population o
47  the diagnosis, treatment, and prevention of protozoal infections of the gastrointestinal tract.
48      Giardia lamblia, one of the most common protozoal infections of the human intestine, is an impor
49           Progress in tackling tuberculosis, protozoal infections, and enteric bacterial diseases has
50 e crucial for immunity to many bacterial and protozoal infections, whereas Th2 cells, which make IL-4
51 multiplex PCR, as well as and microscopy for protozoal infections.
52 mice against subsequent viral, bacterial, or protozoal infections.
53 ads to be optimized into candidates to treat protozoal infections.
54 participate in defense against bacterial and protozoal infections.
55 nomegaly that follows a variety of viral and protozoal infections; this finding raises the question o
56  mammalian membranes, has been used to treat protozoal intestinal infections in human patients.
57 tis neurona is the etiologic agent of equine protozoal myeloencephalitis (EPM).
58 ystis neurona, the etiologic agent of equine protozoal myeloencephalitis.
59 bacterial (Clostridium difficile), and three protozoal (one Giardia lamblia, two Cryptosporidium) inf
60 ction, but can also be induced by bacterial, protozoal or fungal infections as well as a wide variety
61 iviridae, along with several other groups of protozoal or fungal viruses, including Leishmania RNA vi
62  identify a functional role for aquaporin in protozoal osmoregulation.
63    However, we and others have observed that protozoal parasite antigens can induce the proliferation
64 ates with susceptibility to infection by the protozoal parasite Leishmania major.
65                            AdoMetDC from the protozoal parasite Trypanosoma cruzi requires putrescine
66               B. bovis, an intraerythrocytic protozoal parasite, establishes chronic infections in ca
67                                              Protozoal parasites are unusual in that their thymidylat
68  a metabolite common to Escherichia coli and protozoal parasites of the Trypanosoma family.
69            It is caused by intra-erythrocyte protozoal parasites, with Babesia rossi causing the most
70                                 Malaria is a protozoal parasitic disease that is widespread in tropic
71 alus microplus ticks efficiently acquire the protozoal pathogen Babesia equi during acute and persist
72      Resolution of acute infection with this protozoal pathogen is believed to be dependent on produc
73 yptosporidium parvum is a minimally invasive protozoal pathogen of intestinal epithelium that results
74 ope to provide an understanding of the human-protozoal pathogen-microbiome interaction and to specula
75 y the emergence of Cryptosporidium parvum, a protozoal pathogen.
76  quantified a range of viral, bacterial, and protozoal pathogens and one indicator, Enterococcus faec
77 ccines targeting intracellular bacterial and protozoal pathogens are notoriously ineffective at gener
78                High levels of infection with protozoal pathogens may be an adverse consequence of die
79 ainst wild type and resistant strains of the protozoal pathogens Trypanosoma brucei, Trypanosoma cong
80 xamined for a range of bacterial, viral, and protozoal pathogens using traditional and molecular micr
81                       Multiple bacterial and protozoal pathogens utilize gene conversion to generate
82                       Multiple bacterial and protozoal pathogens utilize gene conversion to generate
83                    This review discusses the protozoal pathogens, including Cryptosporidium parvum, G
84 d evaluated infection with 2 disease-causing protozoal pathogens, Toxoplasma gondii and Sarcocystis n
85 ileria spp., which are also tick-transmitted protozoal pathogens.
86 ulating innate and acquired immunity against protozoal pathogens.
87 isease, cancer, cardiovascular diseases, and protozoal pathologies.
88 ila was by means of lytic enzymes within the protozoal phagosome, not by initial spore germination fo
89       This represents the first example of a protozoal PKG.
90 ted innate antiviral immunity as well as pro-protozoal responses.
91           It can also distinguish fungal and protozoal sequences, further elucidating their unique ec
92 insight into how they interact with keystone protozoal species remains elusive.
93 is, which may be applicable to other related protozoal species.
94 w tested this class of analogs against other protozoal species: T. cruzi (Chagas disease), Leishmania
95 udied as a potential anti-cancer and/or anti-protozoal target; however, very little is known about th
96 r the future development of synergistic anti-protozoal therapies.
97 , 37% (7/19) were fungal, and 5% (1/19) were protozoal (Toxoplasma gondii).
98 onses can change the frequency of congenital protozoal transmission.
99 nistic work on the roles of these viruses in protozoal virulence.
100 idence indicates that at least some of these protozoal viruses can likewise enhance the pathogenicity
101                       Understanding of these protozoal viruses, however, lags far behind that of many

 
Page Top